Boussard & Gavaudan Investment Management’s Strata Critical Medical Inc SRTA Stock Holding History

Boussard & Gavaudan Investment Management’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-257,506	Closed	-$2.9M	–	92
2020 Q4	$2.9M	Sell	257,506 -542,494	-68%	-$5.53M	0.41%	27
2020 Q3	$8.09M	Hold	800,000	–	–	1.04%	12
2020 Q2	$7.92K	Hold	800,000	–	–	1.5%	10
2020 Q1	$7.7M	Buy	+800,000	New	+$7.94M	1.67%	12

Other funds holding SRTA

HVCM

HG Vora Capital Management New York $191M AUM 1.23% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

DRS

Deane Retirement Strategies New Orleans, Louisiana $236M AUM 22.39% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCP

Berylson Capital Partners Boston, Massachusetts $41.2M AUM 0.19% 1-Year Est. Return

AGM

Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Boussard & Gavaudan Investment Management's SRTA Position: Q1 2021 in Review

Boussard & Gavaudan Investment Management sold out of Strata Critical Medical Inc (SRTA) in Q1 2021, closing a stake of 257,506 shares — an estimated $2.9M sold.

Boussard & Gavaudan Investment Management first reported a position in SRTA in Q1 2020 and held it in 4 quarters. The position peaked at $8.09M in Q3 2020. 64 funds tracked by Wall St. Rank hold SRTA as of Q1 2021.

Boussard & Gavaudan Investment Management reported no remaining Strata Critical Medical Inc position as of Q1 2021 after selling out during the quarter.
Boussard & Gavaudan Investment Management sold 257,506 Strata Critical Medical Inc shares in Q1 2021, an estimated $2.9M.
Boussard & Gavaudan Investment Management first reported a position in Strata Critical Medical Inc in Q1 2020 and held it in 4 quarters.
Boussard & Gavaudan Investment Management's Strata Critical Medical Inc position peaked at $8.09M in Q3 2020.
64 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2021.

Based on Boussard & Gavaudan Investment Management's 13F filing for Q1 2021, filed 11 May 2021.